Hänseler
Quick Facts: Hänseler
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Herisau, Switzerland
- Website
- https://www.haenseler.ch/en/competences/cdmo-portfolio/
- Modalities
- Semi-solids & Liquids, Oral Liquids, Packaging & Labeling
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Hänseler
Hänseler makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Semi-solids & Liquids, Oral Liquids, Packaging & Labeling. 1 manufacturing site registered with the U.S. FDA. Website: https://www.haenseler.ch/en/competences/cdmo-portfolio/
Signal Score
Hänseler FDA Inspection History
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-09-04 |
Hanseler AG
Herisau
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2022-10-21 |
Hanseler AG
Herisau
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Hänseler FDA 483 Findings 4 observations · 2022-10-21 → 2022-10-21 ?
By subsystem
By severity
- 3 — Moderate: 2
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Investigations of discrepancies, failures
"There is a failure to thoroughly review whether or not the batch has been already distributed."
-
Component written specification
"Component testing is deficient in that each component is not tested for conformity with all appropriate written specifications for purity, strength, and quality."
-
Control procedures to monitor and validate performance
"Control procedures are not established which validate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product."